Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandr V Shustov

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|June 24, 2022
Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-<i>b</i>]Pyridine DerivativesAlena L Stalinskaya, Nadezhda V Martynenko, Zarina T Shulgau, et al.
Journal of Virological Methods|September 17, 2019
Towards development of plasmacytoma cells-based expression systems utilizing alphavirus vectors: An NS0-VEE modelViktoriya V Keyer, Alexandr B Shevtsov, Mikhail M Zaripov, et al.
Biology|June 11, 2026
Development of Replicon Cell Pools Bearing a Flavivirus RNA Replicon as a Source of HIV-1 Gag-Pol for Lentiviral Vector ProductionAitolkyn Kydyrbayeva, Viktoriya Keyer, Tolganay Kulatay, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 22, 2009
Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoesCharles E McGee, Alexandr V Shustov, Konstantin Tsetsarkin, et al.
Biology|February 12, 2026
A Replication-Competent Flavivirus Genome with a Stable GFP Insertion at the NS1-NS2A JunctionPavel Tarlykov, Bakytkali Ingirbay, Dana Auganova, et al.
Biomolecules|August 28, 2025
Introducing CAR-T Therapy in Kazakhstan: Establishing Academic-Scale Lentiviral Vector and CAR-T Cell ProductionViktoriya Keyer, Aitolkyn Kydyrbayeva, Tolganay Kulatay, et al.
Plos One|December 8, 2017
Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vectorYuriy G Kim, Aliya Zh Baltabekova, Erzhan E Zhiyenbay, et al.
Virus Research|January 3, 2021
Fluorescent tagging the NS1 protein in yellow fever virus: Replication-capable viruses which produce the secretory GFP-NS1 fusion proteinLaura R Syzdykova, Stephan Binke, Viktoriya V Keyer, et al.
Frontiers in Microbiology|April 10, 2023
<i>Brucella abortus</i> in Kazakhstan, population structure and comparison with worldwide genetic diversityAlexandr Shevtsov, Axel Cloeckaert, Kalysh Berdimuratova, et al.
Molecules (Basel, Switzerland)|August 26, 2023
<i>Glycyrrhiza glabra</i> L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but OverlookedMurat Zh Zhurinov, Alfira F Miftakhova, Viktoriya Keyer, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|June 24, 2022
Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-<i>b</i>]Pyridine DerivativesAlena L Stalinskaya, Nadezhda V Martynenko, Zarina T Shulgau, et al.
Journal of Virological Methods|September 17, 2019
Towards development of plasmacytoma cells-based expression systems utilizing alphavirus vectors: An NS0-VEE modelViktoriya V Keyer, Alexandr B Shevtsov, Mikhail M Zaripov, et al.
Biology|June 11, 2026
Development of Replicon Cell Pools Bearing a Flavivirus RNA Replicon as a Source of HIV-1 Gag-Pol for Lentiviral Vector ProductionAitolkyn Kydyrbayeva, Viktoriya Keyer, Tolganay Kulatay, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 22, 2009
Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoesCharles E McGee, Alexandr V Shustov, Konstantin Tsetsarkin, et al.
Biology|February 12, 2026
A Replication-Competent Flavivirus Genome with a Stable GFP Insertion at the NS1-NS2A JunctionPavel Tarlykov, Bakytkali Ingirbay, Dana Auganova, et al.
Biomolecules|August 28, 2025
Introducing CAR-T Therapy in Kazakhstan: Establishing Academic-Scale Lentiviral Vector and CAR-T Cell ProductionViktoriya Keyer, Aitolkyn Kydyrbayeva, Tolganay Kulatay, et al.
Plos One|December 8, 2017
Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vectorYuriy G Kim, Aliya Zh Baltabekova, Erzhan E Zhiyenbay, et al.
Virus Research|January 3, 2021
Fluorescent tagging the NS1 protein in yellow fever virus: Replication-capable viruses which produce the secretory GFP-NS1 fusion proteinLaura R Syzdykova, Stephan Binke, Viktoriya V Keyer, et al.
Frontiers in Microbiology|April 10, 2023
<i>Brucella abortus</i> in Kazakhstan, population structure and comparison with worldwide genetic diversityAlexandr Shevtsov, Axel Cloeckaert, Kalysh Berdimuratova, et al.
Molecules (Basel, Switzerland)|August 26, 2023
<i>Glycyrrhiza glabra</i> L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but OverlookedMurat Zh Zhurinov, Alfira F Miftakhova, Viktoriya Keyer, et al.
Pageof 3